About: Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayo clínico (es) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study (en) Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study (nl)
skos:prefLabel	Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study (en) Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study (nl)
name	Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study (en) Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study (nl)
title	wds:Q105789191-9D6FE1B8-224F-43FF-96E1-AB04F838C8E6
title	Phase 2 Response Evaluation of Finite Systemic Therapy With Advanced Androgen Signaling Inhibition and Radiation Therapy for Oligorecurrent Prostate Cancer (RESTART) (en)
end time	wds:Q105789191-250B7819-08BA-4BD3-863E-B1206E080F63
end time	2021-01-08 00:00:00Z (xsd:dateTime)
instance of	wds:Q105789191-203146E2-9A10-4A74-BAAA-660C1A325497
instance of	clinical trial
start time	wds:Q105789191-FE687D4E-7EB9-4322-9B43-BED712F7B46A
start time	2020-11-24 00:00:00Z (xsd:dateTime)
country	wds:Q105789191-8F9BFEAF-2090-4CC4-945B-610AC5B2C005
country	United States of America
research intervention	wds:Q105789191-41C8FBB9-AD9C-4FA0-AE10-1651AA7145D4
research intervention	leuprolide
minimum age	wds:Q105789191-ED0A0743-6872-418B-8FC3-BAC4C69AA659
minimum age	18 (xsd:decimal)
medical condition	wds:Q105789191-41ABE732-9832-49BF-BFFD-D662DB61ECA1
sponsor	wds:Q105789191-26DD046C-617D-4622-89C3-2C553AF6B291
medical condition	carcinoma
sponsor	The University of Texas MD Anderson Cancer Center
number of participants	wds:Q105789191-BE560CAD-58DE-4DB5-A062-2207C9109EB7
number of participants	0 (xsd:decimal)
contributor to the...e work or subject	wds:Q105789191-E8F940E4-9494-4A79-9913-66A131C2AB38
contributor to the...e work or subject	National Cancer Institute
study type	wds:Q105789191-19405A22-C261-489E-9F3C-0B55628FC3DC
study type	interventional study
ClinicalTrials.gov ID	wds:Q105789191-41FAB729-EBE9-4F29-8367-4DBCDFCE2E77
ClinicalTrials.gov ID	NCT04585932
clinical trial phase	wds:Q105789191-F59C32C0-6761-452C-98CA-176772B1AB82
clinical trial phase	phase II clinical trial
research subject recruitment status	wds:Q105789191-F2D3AB4C-C0B3-4CE5-9C5A-8F43B0BEA809
research subject recruitment status	withdrawn
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q105789191

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software